JSE stocks flat, Mediclinic jumps

Comment on this story
IOL image JSE interior view INDEPENDENT MEDIA The JSE is seen in this file photo: Leon Nicholas.

Johannesburg - South African stocks ended flat on Tuesday ahead of a national election but shares of Mediclinic International soared after the private hospital group said its annual earnings likely more than quadrupled.

Mediclinic shares jumped 6 percent to end at 76.50 rand, after earlier hitting 78.47 rand, the stock's highest since the company's listing in 1988, according to Reuters data.

Trade on the Johannesburg bourse was relatively active with 196 million shares changing hands, but some investors held back ahead of a public holiday on Wednesday for the election.

“A lot of investors internationally have put their foot on the brakes until we know the results of the election tomorrow,” said Paul Chakaduka, a trader at Global Trader.

The benchmark Top-40 index was up 0.16 percent to 43,847.58, while the All-share index was up 0.13 percent to 48,942.02.

Other gainers included telecommunication firms with Vodacom rising 1.6 percent to 127.01 rand and MTN Group adding 1.5 percent to 216 rand.

Shares of gold producing firms fell in line with a drop in bullion prices.

Harmony Gold lost 3.4 percent to 34.40 rand, while Gold Fields ended 2.1 percent lower at 43.90 rand.

Advancers outnumbered decliners, 194 to 121, while 54 shares were unchanged. - Reuters

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines